Geriatric Depression Scale (GDS). Recent Evidence and Development ... Best Practices in Nursing Care to Older Adults," developed by the Hartford Institute for Geriatric Nursing.

Older adults who had a negative history of depression ... The Patient-Reported Outcomes Measurement Information System (PROMIS) depression scale was used to determine the depression status.

The following is a summary of “Effectiveness of social and therapeutic horticulture for reducing symptoms of depression and anxiety: a systematic review and meta-analysis,” published in the January ...

The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment ... on the Montgomery-Asberg Depression Rating Scale, compared with 7.6 percent ...

Spravato is the first monotherapy for adults with major depressive disorder ... superior improvement in Montgomery-Asberg Depression Rating Scale (MADRS) total score compared with placebo.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy treatment for major depressive disorder (MDD) in adults who do not respond to ...

While it is estimated that 21 million U.S. adults are living with major ... improvement in average Montgomery-Åsberg Depression Rating Scale (MADRS) total score compared with placebo by day ...